Virulence Determinants for Host Tropism in the Burkholderia cepacia complex
洋葱伯克霍尔德菌复合体中宿主向性的毒力决定因素
基本信息
- 批准号:8665382
- 负责人:
- 金额:$ 19.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-23 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceBacteriaBioinformaticsBiological ModelsBurkholderiaBurkholderia cepacia complexChronic Granulomatous DiseaseCore FacilityCystic FibrosisDNADevelopmentDiseaseEnvironmentGenesGenomeGoalsGram-Negative BacteriaHigh-Throughput Nucleotide SequencingImmunocompromised HostImmunotherapeutic agentIn VitroIndividualInfectionInheritedInterventionKnowledgeLibrariesLifeLungMedical centerMetabolicModelingMusMutationOutputPathway interactionsPeptide Initiation FactorsProcessRoleSpleenSystemTechniquesTestingTexasTropismUniversitiesVirulenceVirulentantimicrobialbasecystic fibrosis mousegenome sequencingin vivoinhibitor/antagonistmortalitymouse modelmutantnovelpathogenpatient populationpublic health relevancetool
项目摘要
DESCRIPTION (provided by applicant): The Burkholderia cepacia complex (Bcc) is a group of Gram-negative bacteria that are ubiquitous in the environment and have emerged as opportunistic pathogens in immunocompromised patients. These bacteria cause significant disease in two seemingly disparate hosts: those with cystic fibrosis (CF) and those with chronic granulomatous disease (CGD). We hypothesize that there are unique and common features of Bcc that make it an opportunistic pathogen in these two life-shortening inherited diseases, in which infection is the primary cause of mortality. Surprisingly, there has not been a comprehensive study to identify the bacterial factors that are common or unique in these infections. Here we propose to identify genes important in both CF and CGD using two distinct mouse models of infection. We have already constructed a transposon mutant library encompassing approximately 60,000 random mutants of the sequenced and annotated Burkholderia cenocepacia strain J2315 using a unique mariner transposon system. Importantly, this strain has already been shown to be virulent in a CF and a CGD mouse model of infection. We will use high-throughput sequencing to identify transposon mutants missing from this library following infection in both a CF and a CGD mouse model system. This negative selection allows us to pool the mutants and use relatively few mice, rather than using large numbers of mice that would be required to screen individual Bcc mutants. Following the identification of factors required for each of these infections, we will focus on those genes important in both CF and CGD. We anticipate that genes needed for adherence and those necessary for metabolic activities in vivo will be recognized as critical for both these infections. We will construct specfic mutations in genes in these pathways and will confirm the role of these factors in the mouse models of infection. We will also determine the effect of these mutations in in vitro and ex vivo models of virulence. A thorough understanding of these processes will allow the identification of potential targets in Bcc for the development of novel antimicrobials, inhibitors, and immunotherapeutic intervention to protect these vulnerable patient populations.
描述(由申请方提供):洋葱伯克霍尔德菌复合体(Bcc)是一组革兰氏阴性菌,在环境中普遍存在,并在免疫功能低下患者中作为机会致病菌出现。这些细菌在两种看似不同的宿主中引起重大疾病:囊性纤维化(CF)和慢性肉芽肿病(CGD)。我们假设,有独特的和共同的特点,使其成为一个机会致病菌在这两个缩短寿命的遗传性疾病,其中感染是死亡的主要原因。令人惊讶的是,目前还没有一项全面的研究来确定这些感染中常见或独特的细菌因素。在这里,我们建议使用两种不同的小鼠感染模型来识别CF和CGD中的重要基因。我们已经使用独特的mariner转座子系统构建了包含测序和注释的新洋葱伯克霍尔德菌菌株J2315的约60,000个随机突变体的转座子突变体文库。重要的是,该菌株已被证明在CF和CGD小鼠感染模型中具有毒性。我们将使用高通量测序来鉴定CF和CGD小鼠模型系统中感染后从该文库中缺失的转座子突变体。这种负选择使我们能够汇集突变体,并使用相对较少的小鼠,而不是使用大量的小鼠来筛选单个Bcc突变体。在确定了这些感染所需的因素之后,我们将重点关注CF和CGD中重要的基因。我们预计,粘附所需的基因和体内代谢活动所需的基因将被认为是这两种感染的关键。我们将在这些途径的基因中构建特异性突变,并将在小鼠感染模型中证实这些因子的作用。我们还将确定这些突变在体外和离体毒力模型中的作用。对这些过程的深入了解将有助于确定Bcc中的潜在靶点,以开发新型抗菌药物、抑制剂和免疫干预,从而保护这些脆弱的患者群体。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single amino acid substitution in homogentisate 1,2-dioxygenase is responsible for pigmentation in a subset of Burkholderia cepacia complex isolates.
- DOI:10.1111/1758-2229.12217
- 发表时间:2015-04
- 期刊:
- 影响因子:3.3
- 作者:Gonyar LA;Fankhauser SC;Goldberg JB
- 通讯作者:Goldberg JB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joanna B Goldberg其他文献
Joanna B Goldberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joanna B Goldberg', 18)}}的其他基金
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
- 批准号:
10674274 - 财政年份:2023
- 资助金额:
$ 19.57万 - 项目类别:
Pyocins as antibacterials to treat Pseudomonas aeruginosa infections
脓毒素作为抗菌药物治疗铜绿假单胞菌感染
- 批准号:
10727705 - 财政年份:2023
- 资助金额:
$ 19.57万 - 项目类别:
Mechanisms of Staphylococcus aureus and Pseudomonas aeruginosa Co-existence in CF
CF中金黄色葡萄球菌和铜绿假单胞菌共存的机制
- 批准号:
10078252 - 财政年份:2020
- 资助金额:
$ 19.57万 - 项目类别:
Impact of Alginate Overproduction on P. aeruginosa LPS O Antigen Expression
海藻酸盐过量生产对铜绿假单胞菌 LPS O 抗原表达的影响
- 批准号:
9317789 - 财政年份:2017
- 资助金额:
$ 19.57万 - 项目类别:
Mechanism of Phosphorylcholination of EF-Tu on Pseudomonas aeruginosa
EF-Tu对铜绿假单胞菌的磷酸胆酸化机制
- 批准号:
8638629 - 财政年份:2014
- 资助金额:
$ 19.57万 - 项目类别:
Mechanism of Phosphorylcholination of EF-Tu on Pseudomonas aeruginosa
EF-Tu对铜绿假单胞菌的磷酸胆酸化机制
- 批准号:
8912974 - 财政年份:2014
- 资助金额:
$ 19.57万 - 项目类别:
Virulence Determinants for Host Tropism in the Burkholderia cepacia complex
洋葱伯克霍尔德菌复合体中宿主向性的毒力决定因素
- 批准号:
8583633 - 财政年份:2013
- 资助金额:
$ 19.57万 - 项目类别:
Purine biosynthesis as a therapeutic target for Helicobacter pylori infection
嘌呤生物合成作为幽门螺杆菌感染的治疗靶点
- 批准号:
8488407 - 财政年份:2012
- 资助金额:
$ 19.57万 - 项目类别:
Purine biosynthesis as a therapeutic target for Helicobacter pylori infection
嘌呤生物合成作为幽门螺杆菌感染的治疗靶点
- 批准号:
8385961 - 财政年份:2012
- 资助金额:
$ 19.57万 - 项目类别:
Purine biosynthesis as a therapeutic target for Helicobacter pylori infection
嘌呤生物合成作为幽门螺杆菌感染的治疗靶点
- 批准号:
8635527 - 财政年份:2012
- 资助金额:
$ 19.57万 - 项目类别:
相似国自然基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
- 批准号:81971557
- 批准年份:2019
- 资助金额:65.0 万元
- 项目类别:面上项目
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
- 批准号:51678163
- 批准年份:2016
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Cell Wall Formation in Rod Shaped Bacteria
杆状细菌细胞壁的形成
- 批准号:
BB/Y003187/1 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Research Grant
Did light dictate ancient diversification of phylogeny and cell structure in the domain bacteria?
光是否决定了细菌领域的古代系统发育和细胞结构的多样化?
- 批准号:
24H00582 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Conference: Symposium on the Immune System of Bacteria
会议:细菌免疫系统研讨会
- 批准号:
2349218 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Standard Grant
DNA replication dynamics in living bacteria
活细菌中的 DNA 复制动态
- 批准号:
23K25843 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Fellowship
Assembly of the matrix that supports bacteria living in biofilms
支持生活在生物膜中的细菌的基质的组装
- 批准号:
2468773 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Studentship
BacNLR - Functional diversity of NLRs in multicellular bacteria
BacNLR - 多细胞细菌中 NLR 的功能多样性
- 批准号:
EP/Z000092/1 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Research Grant
Manipulating two-component systems to activate cryptic antibiotic pathways in filamentous actinomycete bacteria
操纵双组分系统激活丝状放线菌中的神秘抗生素途径
- 批准号:
BB/Y005724/1 - 财政年份:2024
- 资助金额:
$ 19.57万 - 项目类别:
Research Grant